Abstract
NOTEWORTHY EFFECTS OF RIPASUDIL, A RHO-KINASE INHIBITOR, ON OPHTHALMIC PATHOLOGIES

Huma Quadir*, Aswa Gondal, Kshitij Mahajan and Arpit Arora

ABSTRACT

Ripasudil, a rho-associated protein kinase (ROCK) inhibitor, is a coil-coiled protein kinase inhibitor that was first approved in Japan in 2014. ROCK has two isoforms ROCK1 and ROCK 2. Their pathway controls myosin-actin interactions and endothelial function. It has since been used to lower ocular pressure (IOP) by increasing aqueous flow accomplishing a better target intraocular pressure as compared to standard available drugs including B-blockers, carbonic anhydrase inhibitors, alpha 2 agonists, and use of prostaglandins. It has, therefore, been demonstrated as efficacious for the treatment of glaucoma. Due to its activity on tight junctions, it has also been stated useful in treating diabetic macular edema as well as in corneal healing. The efficacy of ripasudil is indirectly related to damage to trabecular meshwork making it less efficacious on irreversible damage and hence, better to start early. Here, we will elaborate on the ophthalmic effects of ripasudil. We also shed light on the side effects of ripasudil use like conjunctival hyperemia and blepharitis.

Keywords: Ripasudil, ROCK inhibitors, Glaucoma, Diabetic macular edema, Intraocular pressure.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: OCTOBER ISSUE PUBLISHED

    OCTOBER 2022 Issue has been successfully launched on 1 October 2022.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT